echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Chinese University of Hong Kong leads discovery of new treatment for intrahepatic cholangiocarcinoma

    Chinese University of Hong Kong leads discovery of new treatment for intrahepatic cholangiocarcinoma

    • Last Update: 2022-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    China News Service, AugustAccording to Hong Kong's "Ta Kung Pao" report, in the past 10 years, the global incidence of intrahepatic cholangiocarcinoma has continued to increa.


    The clinical study was designed and initiated by the Department of Oncology, Faculty of Medicine, The Chinese University of Hong Kong, in collaboration with the Department of Imaging and Interventional Radiolo.


    Professor Yu Junhao, Professor of the Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, explained the efficacy of local therapy in treating intrahepatic cholangiocarcinoma: "SIRT is the treatment of liver tumors by injecting radioactive substances containing 'yttrium 90' through arteri.


    The study results showed that patients who received SIRT alone had a median overall survival of 16 months; patients who received a combination of SIRT and standard chemotherapy had a median overall survival of 26 mont.


    Lead researcher Pr.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.